Physician profile
Allison Rose Taskin
NPI 1730785189
$3,201.50
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,758 · 2022: $1,443.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $408.81 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $364.10 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $333.07 | 2021-2022 | |
| Nevro Corp. | $309.18 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $283.32 | 2021 | |
| Abbvie INC. | $282.00 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $212.08 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $137.64 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $133.96 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $122.07 | 2021-2022 | |
| Hikma Pharmaceuticals USA | $121.16 | 2021-2022 | |
| Grt US Holding, INC. | $111.64 | 2022 | |
| Indivior INC. | $93.51 | 2021 | |
| Lilly USA, LLC | $70.88 | 2021 | |
| Bioventus LLC | $62.72 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electronic Waveform Lab, INC. | $44.63 | 2022 | |
| Almatica Pharma LLC | $35.55 | 2021 | |
| Relievant Medsystems, INC. | $22.32 | 2021 | |
| Novartis Pharmaceuticals Corporation | $19.83 | 2021 | |
| Depuy Synthes Sales INC. | $18.90 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $14.13 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Taskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.